Outcomes in patients with invasive candidiasis treated with anidulafungin or fluconazole: Comparison of response to treatment in ICU patients and/or patients with end-organ dysfunction

被引:0
|
作者
Shorr, Andrew F. [1 ]
Kett, Dan H. [2 ]
Sanchez, Sonia [3 ]
Gasper, Sabina [3 ]
Schlamm, Haran T. [3 ]
机构
[1] Washington Hosp Ctr, Washington, DC 20010 USA
[2] Univ Miami, Miami, FL 33152 USA
[3] Pfizer Inc, New York, NY USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
899
引用
收藏
页码:A250 / A250
页数:1
相关论文
共 50 条
  • [31] Invasive Candidiasis in Patients with Solid Tumors Treated with Anidulafungin: A Post Hoc Analysis of Efficacy and Safety of Six Pooled Studies
    De Rosa, Francesco Giuseppe
    Busca, Alessandro
    Capparella, Maria Rita
    Yan, Jean Li
    Aram, Jalal A.
    CLINICAL DRUG INVESTIGATION, 2021, 41 (06) : 539 - 548
  • [32] Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive CandidiasisFocus on Critically Ill Patients
    Annette C. Reboli
    Coleman Rotstein
    Daniel H. Kett
    Michael Maschio
    Shannon Cartier
    Richard Chambers
    Miriam Tarallo
    PharmacoEconomics, 2011, 29 : 705 - 717
  • [33] Invasive Candidiasis in Patients with Solid Tumors Treated with Anidulafungin: A Post Hoc Analysis of Efficacy and Safety of Six Pooled Studies
    Francesco Giuseppe De Rosa
    Alessandro Busca
    Maria Rita Capparella
    Jean Li Yan
    Jalal A. Aram
    Clinical Drug Investigation, 2021, 41 : 539 - 548
  • [34] Assessing Time to Diagnosis, End-Organ Damage and Treatment Response in Young Newly Diagnosed Multiple Myeloma Patients
    Quan, Michelle A.
    Ang, Kwan-Keat
    Tuscano, Joseph M.
    Abedi, Mehrdad
    Jonas, Brian A.
    Esteghamat, Naseem S.
    Welborn, Jeanna L.
    Kaesberg, Paul R.
    Rosenberg, Aaron S.
    BLOOD, 2022, 140 : 7203 - 7205
  • [35] Treatment of urinary candidiasis with fluconazole. Experience in 24 patients
    Thompson, L
    Pino, M
    Castrillon, MA
    Schenone, D
    delCanto, E
    REVISTA MEDICA DE CHILE, 1995, 123 (12) : 1505 - 1509
  • [36] Fluconazole orally dispersible tablets for the treatment of patients with oropharyngeal candidiasis
    Vandercam, B
    Gibbs, D
    Valtonen, M
    Jager, H
    Armignacco, O
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1998, 26 (04) : 209 - 218
  • [37] Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS
    Hegener, P
    Troke, PF
    Fätkenheuer, G
    Diehl, V
    Ruhnke, M
    AIDS, 1998, 12 (16) : 2227 - 2228
  • [38] Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients
    Menon, T
    Umamaheswari, K
    Kumarasamy, N
    Solomon, S
    Thyagarajan, SP
    ACTA TROPICA, 2001, 80 (02) : 151 - 154
  • [39] The Impact of Overweight and Obesity on End-Organ Function in Fontan Patients
    Gaydos, Stephanie S.
    Chowdhury, Shahryar M.
    Kasi, Nagraj
    Jackson, Lanier
    Woodard, Frances K.
    Atz, Andrew M.
    McHugh, Kimberly E.
    CIRCULATION, 2020, 142
  • [40] FLUCONAZOLE AND KETOCONAZOLE IN THE TREATMENT OF ORAL AND ESOPHAGEAL CANDIDIASIS IN AIDS PATIENTS
    BARCHIESI, F
    GIACOMETTI, A
    ARZENI, D
    BRANCHESI, P
    CRESCENZI, G
    ANCARANI, F
    SCALISE, G
    JOURNAL OF CHEMOTHERAPY, 1992, 4 (06) : 381 - 386